(Bloomberg) U.S. companies looking for lower tax bills are heading for the exits, and Congress is doing nothing to stop them.

Pfizer Inc. is the latest corporation to consider reducing its tax bill by moving its legal address outside the U.S., proposing an acquisition of London-based AstraZeneca Plc that would allow Pfizer to reincorporate in the U.K. while top executives remain in New York.

Register or login for access to this item and much more

All Accounting Today content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access